SSTR2 Imaging With [68Ga]Ga-DOTA-TOC PET/CT in NPC

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 25, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Nasopharyngeal Carcinoma (NPC)
Interventions
OTHER

[68Ga]Ga-DOTA-TOC PET imaging

"Patients will undergo \[68Ga\]Ga-DOTA-TOC PET imaging before and 3 weeks after start of standard of care treatment with induction chemotherapy or CRT, unless the baseline scan shows no tracer uptake in the tumor, in that case the scan will not be repeated.~Patients will receive 120 MBq \[68Ga\]Ga-DOTA-TOC intravenously and will be scanned up to 20 minutes, 60 minutes after tracer injection, after acquisition of a low dose CT for attenuation correction.~The investigators will use archival tissue of the diagnostic biopsy for SSTR2 staining. If there is not sufficient tumor tissue available, a new biopsy will be performed after the baseline PET scan.~Blood samples will be drawn before the start, during and after finishing therapy at 3 or 4 different time points, depending on the treatment schedule."

Trial Locations (1)

9713 GZ

RECRUITING

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT06982300 - SSTR2 Imaging With [68Ga]Ga-DOTA-TOC PET/CT in NPC | Biotech Hunter | Biotech Hunter